Streetbeat News

Equity Actions

REXR

Rexford Industrial Realty, Inc. has announced the pricing of an underwritten public offering of 17,179,318 shares of its common stock at $48.95 per share to an existing West Coast-based long-only investor. The offering is expected to close on March 28, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 6:14 am

BWMN

Bowman has announced a public offering of 1,323,530 shares of common stock at $34 per share, with an additional 147,058 shares being sold by key executives. The offering is expected to generate approximately $45.0 million in gross proceeds for Bowman.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 5:52 am

PGTI

RUN

Sunrun Inc. (RUN) will replace PGT Innovations Inc. (PGTI) in the S&P SmallCap 600 index effective before the market opens on April 1. This change reflects adjustments in the index to better represent the small-cap market segment.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 9:22 pm

ROIV

RUN

Roivant Sciences will replace Sunrun in the S&P MidCap 400 index effective before the market opens on April 1. This change may influence the stock prices of both companies in the short term due to the expected adjustments by funds that track the index.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 9:20 pm

SOFI

Sofi Technologies has completed transactions as per exchange agreements, issuing 72.6M shares of common stock. These exchanges are anticipated to positively impact GAAP net income in Q1 of 2024.

Portfolio Pulse from Charles Gross

March 26, 2024 | 9:15 pm

ANNX

Annexon, Inc. has filed for a mixed shelf offering, allowing the company to sell securities up to $400 million. This move could provide the company with flexible financing options for future growth, acquisitions, or debt management.

Portfolio Pulse from Charles Gross

March 26, 2024 | 9:09 pm

FOX

FOXA

Steven Cohen's Point72 Asset Management, L.P. has reported a 5% stake in Fox Corp as of March 25, 2024, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 8:26 pm

BWMN

Bowman Consulting Group's shares are trading lower following the announcement of a $50 million public offering of common stock. This move could dilute existing shareholders' equity, leading to the current decrease in stock price.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 8:24 pm

KYTX

Kyverna Therapeutics reported a FY23 net loss of $60.4 million, or $89.61 per share, worsening from a $28.9 million loss, or $63.43 per share in FY22. Operating cash use increased to $52.4 million from $36.1 million. As of Dec 31, 2023, it had $57.5 million in liquidity. Post FY23, Kyverna raised $366.9 million in an IPO in February 2024.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 8:20 pm

RCKT

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) announced the appointment of Aaron Ondrey as Chief Financial Officer and made additional key appointments within its leadership team to expand capabilities across the company. These appointments are part of Rocket's preparation for its transition to a commercial stage and the continued development of its genetic therapy pipeline for rare disorders. Aaron Ondrey brings over 20 years of experience in financial management and strategic planning, having previously served as CFO of Mirati Therapeutics and held senior positions at Arena Pharmaceuticals, Alexion Pharmaceuticals, and Regeneron Pharmaceuticals. Other appointments include Kinnari Patel as President and COO, Jonathan Schwartz as Chief Medical & Gene Therapy Officer, Mark White as General Manager of Commercial Affairs, and Martin Wilson as General Counsel & Chief Corporate Officer.

Portfolio Pulse from Happy Mohamed

March 26, 2024 | 8:14 pm